Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-031491
Filing Date
2022-11-14
Accepted
2022-11-14 06:04:24
Documents
56
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1574440
2 ex10-3.htm EX-10.3 36101
3 ex31-1.htm EX-31.1 13246
4 ex31-2.htm EX-31.2 12902
5 ex32-1.htm EX-32.1 6414
6 ex32-2.htm EX-32.2 6385
  Complete submission text file 0001493152-22-031491.txt   4785764

Data Files

Seq Description Document Type Size
7 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rnxt-20220930.xsd EX-101.SCH 26480
8 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rnxt-20220930_cal.xml EX-101.CAL 38541
9 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rnxt-20220930_def.xml EX-101.DEF 107714
10 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rnxt-20220930_lab.xml EX-101.LAB 258659
11 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rnxt-20220930_pre.xml EX-101.PRE 199069
50 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 591990
Mailing Address 333 W. SANTA CLARA STREET, SUITE 900 SAN JOSE CA 95110
Business Address 333 W. SANTA CLARA STREET, SUITE 900 SAN JOSE CA 95110 408-800-2649
RenovoRx, Inc. (Filer) CIK: 0001574094 (see all company filings)

EIN.: 271448452 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40738 | Film No.: 221379512
SIC: 2834 Pharmaceutical Preparations